Tenderwize
Back to tender search

Open house drug discount contracts for formoterol, glycopyrronium bromide and budesonide

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 131 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Formoterol, Glycopyrroniumbromid und Budesonid , ATC R03AL11

54/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

54 / 100

Complexity

66 / 100

Risk factors

No guaranteed volume, expenditure, or contract value is stated, so participation does not establish a predictable reven...

The buyer may replace the non-exclusive agreements with exclusive agreements, causing the open-house contracts to end u...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 31, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive pharmaceutical discount agreements with AOK Rheinland-Pfalz/Saarland.
  • Medicines containing Formoterol, Glycopyrronium bromide and Budesonide, ATC R03AL11, are within scope.
Show full summary

Open-house arrangement for non-exclusive pharmaceutical discount agreements covering Formoterol, Glycopyrronium bromide and Budesonide (ATC R03AL11) with AOK Rheinland-Pfalz/Saarland. Eligible pharmaceutical companies may join without a competitive selection decision, subject to uniform non-negotiable contractual conditions and proof that the medicines are authorised and marketable in Germany. The arrangement is planned for 1 June 2025 to 31 May 2027, but the structured submission deadline is 31 March 2027 and the XML notice also records that date. Procurement documents are referenced but their extracted contents were not provided. No contract value is disclosed.

Risks

No guaranteed volume, expenditure, or contract value is stated, so participation does not establish a predictable reven...

The buyer may replace the non-exclusive agreements with exclusive agreements, causing the open-house contracts to end u...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Participation is open to interested pharmaceutical companies and is non-exclusive.
  • Only medicines authorised and marketable in Germany may generally be supplied under the agreement.

Administrative

  • The contractual conditions, terms and access procedure are uniform for all participants; individual negotiations are not conducted.

Award Criteria

Lot 1

No lot-specific award criteria are provided; the notice states that participation occurs without a selection decision.

Buyer

Lots (1)

LOT-0001

Open-house pharmaceutical discount agreements for Formoterol, Glycopyrronium bromide and Budesonide

Non-exclusive discount agreements under sections 130a(8) and 130c(1) SGB V for medicines containing the specified active substances under ATC R03AL11. All interested pharmaceutical companies may join under identical conditions, without individual negotiation or a selection decision. Medicines included in the BfArM list under section 35(5a) SGB V for children's medicines are excluded. Lot information is derived from structured tender data and the XML notice.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No lot-specific award criteria are provided; the notice states that participation occurs without a selection decision.

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
237520-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy